Skip to main content
Log in

Risk of Systemic Inflammatory Response Syndrome Following Preoperative Glucocorticoids Administration in Patients After Percutaneous Nephrolithotomy: A Retrospective Cohort Study

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Introduction

Systemic inflammatory response syndrome (SIRS) is one of the most serious complications in patients undergoing percutaneous nephrolithotomy (PCNL). Although glucocorticoids are increasingly used during PCNL, few studies have been concerned about the association between glucocorticoids and postoperative SIRS. The study aims to explore whether preoperative use of glucocorticoids is associated with SIRS after PCNL.

Methods

A total of 1259 patients who underwent PCNL between January 2015 and April 2021 were enrolled in the retrospective cohort study. Risk factors for post-PCNL SIRS were identified by univariate and multivariate regression analysis. To further explore the association between preoperative administration of glucocorticoids and SIRS, 113 pairs of patients were matched for the confounding factors using propensity score matching (PSM) analysis. The odds ratios (OR) and 95 % confidence intervals (CI) for the above variables were analyzed.

Results

The incidence of SIRS after PCNL was 9.6 % (121/1259) and the patients who suffered from postoperative SIRS had longer hospital stays and higher hospital costs (all p < 0.05). Multivariate logistic regression analysis indicated that female, preoperative leukocyte count, insertion of central vein catheter, serum albumin, preoperative high-sensitive C-reactive protein/albumin ratio, preoperative transfusion, preoperative administration of glucocorticoids were independent risk factors for SIRS (all p < 0.05). After minimization, the effects of confounding factors by PSM, preoperative administration of glucocorticoids was significantly correlated with SIRS in patients after PCNL (OR=2.44, 95 %CI: 1.31–4.55, p = 0.005).

Conclusion

Preoperative administration of glucocorticoids is an independent risk factor for SIRS in patients undergoing PCNL.

Plain Language Summary

Systemic inflammatory response syndrome (SIRS) is a frequent and severe complication in patients underwent percutaneous nephrolithotomy (PCNL), which can be challenging to diagnose early, potentially leading to delayed treatment. Identifying SIRS risk factors and promptly treating high-risk patients is crucial. Glucocorticoids are commonly used to prevent SIRS in clinical practice, and this study aims to investigate whether preoperative glucocorticoid administration is associated with SIRS after PCNL. In total, 1259 patients underwent PCNL and were enrolled in the study. The study utilized both propensity score matching (PSM) analysis and regression analysis to identify risk factors for post-PCNL SIRS. The incidence of SIRS after PCNL was 9.6 % in the study and patients with postoperative SIRS had longer hospital stays and higher hospital costs. After minimizing the potential influence of confounding factors through the use of PSM, we found a significant association between the preoperative use of glucocorticoids and the occurrence of SIRS in patients undergoing PCNL. Based on our analysis, we can conclude that the preoperative administration of glucocorticoids represents an independent risk factor for the development of SIRS in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Khan SR, Pearle MS, Robertson WG, et al. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Siener R. Nutrition and kidney stone disease. Nutrients. 2021. https://doi.org/10.3390/nu13061917.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zeng G, Cai C, Duan X, et al. Mini percutaneous nephrolithotomy is a noninferior modality to standard percutaneous nephrolithotomy for the management of 20–40 mm renal calculi: a multicenter randomized controlled trial. Eur Urol. 2021;79(1):114–21. https://doi.org/10.1016/j.eururo.2020.09.026.

    Article  PubMed  Google Scholar 

  4. Wollin DA, Preminger GM. Percutaneous nephrolithotomy: complications and how to deal with them. Urolithiasis. 2018;46(1):87–97. https://doi.org/10.1007/s00240-017-1022-x.

    Article  PubMed  Google Scholar 

  5. Tang Y, Zhang C, Mo C, et al. Predictive model for systemic infection after percutaneous nephrolithotomy and related factors analysis. Front Surg. 2021;8: 696463. https://doi.org/10.3389/fsurg.2021.696463.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Singh P, Yadav S, Singh A, et al. Systemic inflammatory response syndrome following percutaneous nephrolithotomy: assessment of risk factors and their impact on patient outcomes. Urol Int. 2016;96(2):207–11. https://doi.org/10.1159/000441954.

    Article  CAS  PubMed  Google Scholar 

  7. Akkas F, Karadag S, Haciislamoglu A. Does the duration between urine culture and percutaneous nephrolithotomy affect the rate of systemic inflammatory response syndrome postoperatively? Urolithiasis. 2021;49(5):451–6. https://doi.org/10.1007/s00240-021-01245-7.

    Article  PubMed  Google Scholar 

  8. Deng Y, Tan F, Gan X, et al. Perioperative application of dexmedetomidine for postoperative systemic inflammatory response syndrome in patients undergoing percutaneous nephrolithotomy lithotripsy: results of a randomised controlled trial. BMJ Open. 2018;8(11): e019008. https://doi.org/10.1136/bmjopen-2017-019008.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014;5(1):20–6. https://doi.org/10.4161/viru.27135.

    Article  PubMed  Google Scholar 

  10. Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: a review of advances in management. Adv Ther. 2017;34(11):2393–411. https://doi.org/10.1007/s12325-017-0622-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–247. https://doi.org/10.1097/CCM.0000000000005337.

    Article  PubMed  PubMed Central  Google Scholar 

  12. De Oliveira Jr GS, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy RJ. Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg. 2013;116(1):58–74. https://doi.org/10.1213/ANE.0b013e31826f0a0a.

    Article  CAS  PubMed  Google Scholar 

  13. Qi T, Qi X, Chen X, Jin X. The retrospective study of perioperative application of dexamethasone and furosemide for postoperative anti-inflammation in patients undergoing percutaneous nephrolithotomy. Int Urol Nephrol. 2021;53(4):669–77. https://doi.org/10.1007/s11255-020-02718-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chen C, Yang D, Gao S, et al. Development and performance assessment of novel machine learning models to predict pneumonia after liver transplantation. Respir Res. 2021;22(1):94. https://doi.org/10.1186/s12931-021-01690-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chan JY, Wong VK, Wong J, et al. Predictors of urosepsis in struvite stone patients after percutaneous nephrolithotomy. Investig Clin Urol. 2021;62(2):201–9. https://doi.org/10.4111/icu.20200319.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Serafim R, Gomes JA, Salluh J, Póvoa P. A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest. 2018;153(3):646–55. https://doi.org/10.1016/j.chest.2017.12.015.

    Article  PubMed  Google Scholar 

  17. Zakharova VV, Pletjushkina OY, Zinovkin RA, Popova EN, Chernyak BV. Mitochondria-targeted antioxidants and uncouplers of oxidative phosphorylation in treatment of the systemic inflammatory response syndrome (SIRS). J Cell Physiol. 2017;232(5):904–12. https://doi.org/10.1002/jcp.25626.

    Article  CAS  PubMed  Google Scholar 

  18. Whitlock RP, Devereaux PJ, Teoh KH, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(10000):1243–53. https://doi.org/10.1016/s0140-6736(15)00273-1.

    Article  CAS  PubMed  Google Scholar 

  19. Kallidonis P, Tsaturyan A, Lattarulo M, Liatsikos E. Minimally invasive percutaneous nephrolithotomy (PCNL): techniques and outcomes. Turk J Urol. 2020;46(Supp. 1):S58–63. https://doi.org/10.5152/tud.2020.20161.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wang C, Xu R, Zhang Y, et al. Nomograms for predicting the risk of SIRS and urosepsis after uroscopic minimally invasive lithotripsy. Biomed Res Int. 2022;2022:6808239. https://doi.org/10.1155/2022/6808239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233–47. https://doi.org/10.1038/nri.2017.1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Vandewalle J, Libert C. Glucocorticoids in sepsis: to be or not to be. Front Immunol. 2020;11:1318. https://doi.org/10.3389/fimmu.2020.01318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cicarelli DD, Benseñor FE, Vieira JE. Effects of single dose of dexamethasone on patients with systemic inflammatory response. Sao Paulo Med J. 2006;124(2):90–5. https://doi.org/10.1590/s1516-31802006000200008.

    Article  PubMed  Google Scholar 

  24. Zhou J, Chen C, Cheng N, et al. Perioperative administration of methylprednisolone was associated with postoperative pulmonary complications in elderly patients undergoing hip fracture surgery. Aging Clin Exp Res. 2022;34(9):2005–12. https://doi.org/10.1007/s40520-022-02166-0.

    Article  PubMed  Google Scholar 

  25. Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113. https://doi.org/10.1213/ane.0000000000000002.

    Article  PubMed  Google Scholar 

  26. Lemieux SM, Levine AR. Low-dose corticosteroids in septic shock: has the pendulum shifted? Am J Health Syst Pharm. 2019;76(8):493–500. https://doi.org/10.1093/ajhp/zxz017.

    Article  PubMed  Google Scholar 

  27. Fang F, Zhang Y, Tang J, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(2):213–23. https://doi.org/10.1001/jamainternmed.2018.5849.

    Article  PubMed  Google Scholar 

  28. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38. https://doi.org/10.1038/nri.2016.90.

    Article  CAS  PubMed  Google Scholar 

  29. Reynés G, Vila V, Martín M, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol. 2011;102(1):35–41. https://doi.org/10.1007/s11060-010-0290-x.

    Article  CAS  PubMed  Google Scholar 

  30. Xu H, Hu L, Wei X, et al. The predictive value of preoperative high-sensitive C-reactive protein/albumin ratio in systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol. 2019;33(1):1–8. https://doi.org/10.1089/end.2018.0632.

    Article  PubMed  Google Scholar 

  31. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dunne JR, Malone DL, Tracy JK, Napolitano LM. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt). 2004;5(4):395–404. https://doi.org/10.1089/sur.2004.5.395.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shaoli Zhou, Haiyan Mai or Chulian Gong.

Ethics declarations

Funding

This study was supported partly by the National Natural Science Foundation of China (Grant No. 82102297), Natural Science Foundation of Guangdong Province (Grant No. 2022A1515012603), Young Talent Support Project of Guangzhou Association for Science and Technology (Grant No. QT20220101257), the “Five and five” Project of the Third Affiliated Hospital of Sun Yat-Sen University (grant No. 2023WW501) and Science and Technology Planning Project of Guangdong Province-Regional Innovation Capacity and Support System Construction (grant No. 2023B110006).

Conflict of interest

Not applicable.

Ethics approval

This study was conducted in accordance with the Declaration of Helsinki and the protocol and it was approved by the Ethics Committee of our hospital on 14 May 2019 (No. [2019]02–609-02). The requirement for informed consent and clinical trial registration were waived by the committee.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

The data and material are available from the corresponding author on reasonable request.

Code availability

Not applicable.

Author contributions

JPH: data collection, data analysis and write-up of manuscript. CJC and XYL: data collection, data analysis and interpretation. JK: study design, data analysis, and interpretation. XYZ: data collection and critical review of manuscript. SLZ, HYM and CLG: study conception, study design, data analysis and interpretation and critical review of manuscript. All authors read and approved the final version of this manuscript.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, J., Chen, C., Li, X. et al. Risk of Systemic Inflammatory Response Syndrome Following Preoperative Glucocorticoids Administration in Patients After Percutaneous Nephrolithotomy: A Retrospective Cohort Study. Drug Saf 47, 465–474 (2024). https://doi.org/10.1007/s40264-024-01402-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-024-01402-y

Navigation